RareSum develops physician-centric solutions using multimodal AI technologies to accelerate earlier and more accurate rare disease diagnoses. The platform analyzes unstructured medical data using specialized NLP and disease-specific algorithms to provide decision support and research assistance. The company partners with healthcare professionals, laboratories, and pharmaceutical companies to streamline the diagnostic pathway and improve patient outcomes.
Funding
Funding not disclosed
Founders
Product
Problem
Diagnosing rare diseases is challenging due to the vast number of conditions, limited awareness, and the difficulty in connecting specific symptoms to the correct underlying disorder. Physicians often face extensive research and may struggle to identify relevant testing options, leading to delays in diagnosis and treatment.
Solution
RareSum is an AI-powered platform designed to aid healthcare professionals in the diagnosis of rare diseases. The platform enables users to create detailed patient profiles by extracting information from various sources, including text, files, and manual input. RareSum then uses generative AI to perform deep searches, providing tailored information and relevant testing options specific to each patient's unique presentation. By providing quick access to relevant information, RareSum aims to increase suspicion of rare diseases and drive physicians to pursue appropriate testing, ultimately leading to earlier and more accurate diagnoses.
Target Audience
The primary target audience includes physicians and other healthcare professionals involved in the diagnosis and management of rare diseases.
Features
- Multimodal AI for extracting signs and symptoms from patient data, including text, files, and manual input.
- Generative AI for deep searching and identifying relevant testing options.
- Creation of detailed patient profiles to refine search results.
- Tailored information delivery based on individual patient characteristics.
- Aims to decrease research time for physicians.
- Provides relevant results specific to each patient, rather than general data.